Pharmacist-led antibiotic review for respiratory infections
Part of Infections, Lungs & breathing clinical trials.
This study tests whether a pharmacist-led deprescribing strategy—carefully reviewing and possibly reducing or stopping antibiotics that may not be needed—can improve safety and outcomes in patients with respiratory infections taking azithromycin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a respiratory tract infection (like bronchitis or pneumonia) and are taking the antibiotic azithromycin.
- You are not sick enough to need intensive care (ICU) at the time you join.
- You are not pregnant or breastfeeding.
- You are not taking part in another research study that could affect your azithromycin treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 study tests whether a long course of azithromycin can reduce flare-ups in people with chronic obstructive pulmonary disease (COPD) who have had recent exacerbations. It also looks at mucus properties and how flare-ups happen.
This study tests whether a common antibiotic called azithromycin can help prevent flare-ups (sudden worsening) of bronchiectasis—a lung condition where airways become permanently enlarged and damaged. Patients will take azithromycin or a placebo for 12 months to see if it reduces how often they get sick.
This trial tests whether giving a low dose of azithromycin (an antibiotic) can prevent lung infections in young children with structural lung damage or congenital lung/airway malformations. The goal is to reduce infections and keep lungs healthier.
This Phase 4 study looks at optimizing how people with COPD take azithromycin to reduce flare-ups (exacerbations). If you already take azithromycin regularly, the trial may test ways to improve how it’s used safely.
This study tests whether adding a long-term, low-dose antibiotic (azithromycin) to your usual asthma treatment can help improve control and reduce attacks. It is for people whose asthma is still not well controlled despite using a daily inhaler.
This trial tests whether the antibiotic azithromycin can help children in the hospital who are having asthma-like breathing symptoms. If you qualify, your child may get azithromycin as part of the study and will be monitored closely for side effects and breathing improvement.
Hear when a new Respiratory Tract Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.